Profusa, Inc. (PFSA) shares climbed 95.6% during pre-market hours on Tuesday, August 18, nearly doubling from the previous session's close, after the company completed its third reverse stock split of 2026.

The surge extended a rally that had already built through Monday's regular session and after-hours trading. Profusa ended Monday's session at $4.53, a 27% gain, before rocketing an additional 77% in after-hours activity to reach $8.02. When pre-market trading commenced on Tuesday, the stock had climbed a further 95.6% from Monday's closing price, leaving it within reach of doubling before the regular session even opened.

Reverse Split Drove the Move

The catalyst behind the surge is largely structural. Profusa implemented a 1-for-4 reverse stock split that became effective at 12:01 a.m. ET on August 17, marking the company's third such action in 2026. The move came on the heels of a 1-for-25 consolidation completed on July 7. Stacked together, those two actions alone amount to a 1-for-100 consolidation of the share count in roughly six weeks.

The 1-for-4 split reduced outstanding shares from 2,422,906 to approximately 605,726, and a fresh CUSIP identifier was issued. Tuesday's pre-market session was the first trading session in which market participants fully incorporated the revised share structure.

Reverse splits mechanically reprice existing shares into fewer, higher-priced ones without changing a company's underlying market capitalization, and small-cap issuers most often use them to push a sagging stock back above the $1.00 minimum bid price required for continued listing on major U.S. exchanges.

When the available float becomes this compressed, minimal trading activity can trigger substantial price fluctuations. Even limited buying interest translates into significant percentage gains, creating an environment that attracts short-term, momentum-focused traders. The effect is amplified in pre-market hours, when participation is thinnest and spreads are at their widest.

Acquisition Activity Provides an Additional Catalyst

Separate from the split dynamics, Profusa has been constructing an M&A storyline that has kept speculative attention on the stock elevated. In early August, the firm entered into an option agreement targeting the acquisition of G3 Vision Labs, a diagnostics company already generating commercial revenue.

A letter of intent also remains outstanding for acquiring the PanOmics multi-omics diagnostics platform. Neither transaction has reached completion, but the M&A developments provide traders with fundamental talking points beyond the technical aspects of the share consolidation and the split-driven float dynamics.

A delayed quarterly filing with the U.S. Securities and Exchange Commission (SEC), announced on August 14, attracted additional scrutiny to the stock in the days preceding the price action. Delayed filings do not automatically signal problems, but they frequently draw heightened market attention. The concrete milestones that would give the move fundamental substance are the ones still pending: whether the delayed quarterly report arrives and what its financials show, and whether either the G3 Vision Labs option or the PanOmics letter of intent advances toward a definitive, completed transaction.

Market Conditions Provided No Support

The broader market backdrop offered no assistance for the rally. The Nasdaq declined 1.3% while the S&P 500 fell 0.5% during the same period, underscoring that the price movement was entirely company-specific in nature.

Profusa specializes in continuous biochemistry monitoring technology, including its Lumee Oxygen and Lumee Glucose monitoring systems. The company's work sits alongside a far larger, established continuous glucose monitoring market served by companies such as Abbott Laboratories and Dexcom, which frames the scale of the industry its biointegrated sensor technology targets. No industry-wide developments in digital health or biointegrated sensor technology emerged to justify the surge, and the company issued no earnings announcement or significant revenue disclosure.

The dramatic price action resulted from the convergence of an extremely limited float, reverse split mechanics, and speculative trading momentum, carrying PFSA from Monday's $4.53 close to $8.02 in after-hours trading and higher still into Tuesday's pre-market session.

Source: Blockonomi